Cargando…
The Challenge of High Coronary Thrombotic Events in Patients with ST-Segment Elevation Myocardial Infarction and COVID-19
The aim of this observational study was to describe the characteristics and outcomes of coronavirus disease 2019 (COVID-19)-positive patients with ST-segment elevation myocardial infarction (STEMI), with a special focus on factors associated with a high risk of coronary thrombosis and in-hospital mo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654578/ https://www.ncbi.nlm.nih.gov/pubmed/36362770 http://dx.doi.org/10.3390/jcm11216542 |
_version_ | 1784828967361970176 |
---|---|
author | Anghel, Larisa Tudurachi, Bogdan-Sorin Leonte, Andreea Sascău, Radu Andy Zota, Ioana Mădălina Bazyani, Amin Tinică, Grigore Stătescu, Cristian |
author_facet | Anghel, Larisa Tudurachi, Bogdan-Sorin Leonte, Andreea Sascău, Radu Andy Zota, Ioana Mădălina Bazyani, Amin Tinică, Grigore Stătescu, Cristian |
author_sort | Anghel, Larisa |
collection | PubMed |
description | The aim of this observational study was to describe the characteristics and outcomes of coronavirus disease 2019 (COVID-19)-positive patients with ST-segment elevation myocardial infarction (STEMI), with a special focus on factors associated with a high risk of coronary thrombosis and in-hospital mortality. Comparing the two groups of patients with STEMI separated according to the presence of SARS-CoV-2 infections, it was observed that COVID-19 patients were more likely to present with dyspnea (82.43% vs. 61.41%, p = 0.048) and cardiogenic shock (10.52% vs. 5.40%, p = 0.012). A longer total ischemia time was observed in COVID-19 patients, and they were twice as likely to undergo coronary angiography more than 12 hours after the onset of symptoms (19.29% vs. 10.13%, p = 0.024). In 10 of 57 COVID-19-positive patients, a primary PCI was not necessary, and only thromboaspiration was performed (17.54% vs. 2.70%, p < 0.001). Platelet level was inversely correlated (r = −0.512, p = 0.025) with a higher risk of coronary thrombosis without an atherosclerotic lesion. Using a cut-off value of 740 ng/ml, D-dimers predicted a higher risk of coronary thrombosis, with a sensitivity of 80% and a specificity of 66% (ROC area under the curve: 0.826, 95% CI: 0.716–0.935, p = 0.001). These are novel findings that raise the question of whether more aggressive antithrombotic therapy is necessary for selected COVID-19 and STEMI patients. |
format | Online Article Text |
id | pubmed-9654578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96545782022-11-15 The Challenge of High Coronary Thrombotic Events in Patients with ST-Segment Elevation Myocardial Infarction and COVID-19 Anghel, Larisa Tudurachi, Bogdan-Sorin Leonte, Andreea Sascău, Radu Andy Zota, Ioana Mădălina Bazyani, Amin Tinică, Grigore Stătescu, Cristian J Clin Med Article The aim of this observational study was to describe the characteristics and outcomes of coronavirus disease 2019 (COVID-19)-positive patients with ST-segment elevation myocardial infarction (STEMI), with a special focus on factors associated with a high risk of coronary thrombosis and in-hospital mortality. Comparing the two groups of patients with STEMI separated according to the presence of SARS-CoV-2 infections, it was observed that COVID-19 patients were more likely to present with dyspnea (82.43% vs. 61.41%, p = 0.048) and cardiogenic shock (10.52% vs. 5.40%, p = 0.012). A longer total ischemia time was observed in COVID-19 patients, and they were twice as likely to undergo coronary angiography more than 12 hours after the onset of symptoms (19.29% vs. 10.13%, p = 0.024). In 10 of 57 COVID-19-positive patients, a primary PCI was not necessary, and only thromboaspiration was performed (17.54% vs. 2.70%, p < 0.001). Platelet level was inversely correlated (r = −0.512, p = 0.025) with a higher risk of coronary thrombosis without an atherosclerotic lesion. Using a cut-off value of 740 ng/ml, D-dimers predicted a higher risk of coronary thrombosis, with a sensitivity of 80% and a specificity of 66% (ROC area under the curve: 0.826, 95% CI: 0.716–0.935, p = 0.001). These are novel findings that raise the question of whether more aggressive antithrombotic therapy is necessary for selected COVID-19 and STEMI patients. MDPI 2022-11-04 /pmc/articles/PMC9654578/ /pubmed/36362770 http://dx.doi.org/10.3390/jcm11216542 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Anghel, Larisa Tudurachi, Bogdan-Sorin Leonte, Andreea Sascău, Radu Andy Zota, Ioana Mădălina Bazyani, Amin Tinică, Grigore Stătescu, Cristian The Challenge of High Coronary Thrombotic Events in Patients with ST-Segment Elevation Myocardial Infarction and COVID-19 |
title | The Challenge of High Coronary Thrombotic Events in Patients with ST-Segment Elevation Myocardial Infarction and COVID-19 |
title_full | The Challenge of High Coronary Thrombotic Events in Patients with ST-Segment Elevation Myocardial Infarction and COVID-19 |
title_fullStr | The Challenge of High Coronary Thrombotic Events in Patients with ST-Segment Elevation Myocardial Infarction and COVID-19 |
title_full_unstemmed | The Challenge of High Coronary Thrombotic Events in Patients with ST-Segment Elevation Myocardial Infarction and COVID-19 |
title_short | The Challenge of High Coronary Thrombotic Events in Patients with ST-Segment Elevation Myocardial Infarction and COVID-19 |
title_sort | challenge of high coronary thrombotic events in patients with st-segment elevation myocardial infarction and covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654578/ https://www.ncbi.nlm.nih.gov/pubmed/36362770 http://dx.doi.org/10.3390/jcm11216542 |
work_keys_str_mv | AT anghellarisa thechallengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT tudurachibogdansorin thechallengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT leonteandreea thechallengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT sascauraduandy thechallengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT zotaioanamadalina thechallengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT bazyaniamin thechallengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT tinicagrigore thechallengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT statescucristian thechallengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT anghellarisa challengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT tudurachibogdansorin challengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT leonteandreea challengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT sascauraduandy challengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT zotaioanamadalina challengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT bazyaniamin challengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT tinicagrigore challengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 AT statescucristian challengeofhighcoronarythromboticeventsinpatientswithstsegmentelevationmyocardialinfarctionandcovid19 |